The influence of ventricular fibrillation duration on defibrillation efficacy using biphasic waveforms in humans
Stephan Windecker, MDa,
Raymond E. Ideker, MD, PhD, FACCa,
Vance J. Plumb, MD, FACCa,
G. Neal Kay, MD, FACCa,
Gregory P. Walcott, MDa and
Andrew E. Epstein, MD, FACCa
a Division of Cardiovascular Disease, Department of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA
View larger version (21K):
[in a new window]
|
Figure 1 Description of the patient groups. VF = ventricular fibrillation.
|
|
View larger version (15K):
[in a new window]
|
Figure 2 Change in the defibrillation threshold energy at ventricular fibrillation (VF) durations of 5 and 10 s.
|
|
View larger version (15K):
[in a new window]
|
Figure 3 Change in the defibrillation threshold energy at ventricular fibrillation (VF) durations of 10 and 20 s.
|
|
View larger version (15K):
[in a new window]
|
Figure 4 Change in the defibrillation threshold energy at ventricular fibrillation (VF) durations of 5 and 20 s.
|
|
View larger version (15K):
[in a new window]
|
Figure 5 Grouped data for the defibrillation threshold energy for all patients (20 each tested at 5, 10 and 20 s of ventricular fibrillation [VF], respectively).
|
|
|
